Contrast-enhanced ultrasound (CEUS) is safe and accurate diagnostic imaging for pregnant women who develop a medical problem or a suspicious tumor.

Venous hypertension affects veins in the legs and the way blood circulates to the heart. Learn about symptoms of venous ...

Kalangala currently has no major hospital and relies on Kalangala and Bukasa Health Centre IVs, located in Kalangala Town Council and Bukasa Island, respectively. Thank you for reading Nation.Africa ...

Services will include remote monitoring, blood tests, and ultrasound imaging. Farrer Park Hospital and Alliance Healthcare Group Limited have partnered to introduce a new home recovery programme to ...

Venous stasis dermatitis, or varicose eczema, involves swollen and itchy discolored skin on the lower legs. It usually occurs when venous insufficiency leads to varicose veins. It can lead to ...

Contrast-enhanced ultrasound (CEUS) has emerged as a promising complement to conventional imaging modalities, offering distinct advantages such as real-time dynamic imaging, cost-effectiveness, and ...

iv and among U.S. health systems, 81% report radiology technologist shortages.v To help address these challenges, GE HealthCare and NVIDIA plan to explore the development of autonomous ultrasound ...

As ultrasound grows in popularity—and complexity ... Approximately 90% of sonographers report work-related musculoskeletal disorders, iv and among U.S. health systems, 81% report radiology ...

An ultrasound scan is a procedure that uses high frequency sound waves to create a picture of a part of the inside of your body. The ultrasound scanner has a probe that gives off sound waves. The ...

Educational videos discussing a general overview of the purpose of nerve blocks, how they are placed, and how to take care of yourself after having one. For any other questions at any time, please ...

Findings showed after 52 weeks, significant improvements in 2MWD and 6MWD were seen with Flebogamma 5% DIF 1mg/kg compared with placebo. Topline data were announced from a phase 2/3 trial ...